Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-21-000085
Filing Date
2021-01-15
Accepted
2021-01-15 13:15:48
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING REGENXBIO INC. REGENXBIO_Inc.htm SC 13G 87942
  Complete submission text file 0000019617-21-000085.txt   89935
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89108
SIC: 2836 Biological Products, (No Diagnostic Substances)